Hospital Santa Rita

Vitória, Espírito Santo 29043-260

0 studies enrolling now · 3 studies all time

What they study most

Adjuvant, Cervical Cancer, EGFR, Early Stage Lung Cancer, Exon 20, Limited Stage Small Cell Lung Cancer, Lung Cancer, NSCLC, Stage IB-IIIA, Post-surgical, Small Cell Lung Cancer, Uncommon EGFR Mutations

Studies at this site

• A Study to Assess the Efficacy and Safety of Zipalertinib Versus Placebo for Adjuvant Treatment in Participants With Stage IB-IIIA NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection — Running, not enrolling
• Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC) — Running, not enrolling
• RaPiDS- A Phase 2 Study of Anti-PD-1 Independently or in Combination With Anti-CTLA-4 in Second-Line Cervical Cancer — Stopped early